articleThe Lancet OncologyDec 5, 2017GREEN OA

Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial

Sarah Cannon · Cancer Research Foundation · +20 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

588
total citations
FWCI
70.53
Percentile
100%
References
43
Citations per year

Authors

18

Topics & keywords

Keywords
  • Avelumab
  • Medicine
  • Metastatic Urothelial Carcinoma
  • Internal medicine
  • Oncology
  • Response Evaluation Criteria in Solid Tumors
  • Javelin
  • Cisplatin
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding